OxyContin maker will stop promoting opioids to doctors

February 10, 2018
OxyContin maker will stop promoting opioids to doctors
This Feb. 19, 2013 file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. The maker of the powerful painkiller said it will stop marketing opioid drugs to doctors, a surprise reversal after lawsuits blaming the company for helping trigger the current drug abuse epidemic. OxyContin has long been the world's top-selling opioid painkiller and generated billions in sales for privately-held Purdue. (AP Photo/Toby Talbot, File)

The maker of the powerful painkiller OxyContin said it will stop marketing opioid drugs to doctors, a surprise reversal following lawsuits that blamed the company for helping trigger the current drug abuse epidemic.

OxyContin has long been the world's top-selling opioid painkiller. It generated billions in sales for privately-held Purdue.

The pill, a time-release version of oxycodone, was hailed as a breakthrough treatment for when it was approved in late 1995. But some users quickly discovered they could get a heroin-like high by crushing the pills and snorting or injecting the entire dose at once.

Purdue's promotions exaggerated the drug's safety and risks of addiction, leading to and federal investigations. But the drug continued to rack up blockbuster sales.

Explore further: FDA panel: Not enough data to OK "abuse-deterrent" opioid

Related Stories

FDA panel: Not enough data to OK "abuse-deterrent" opioid

July 26, 2017
A panel of Food and Drug Administration advisers voted against approving a new opioid painkiller with a unique feature for deterring abuse: It releases a deep-blue dye if someone tries to get high by crushing, chewing or ...

Alabama files lawsuit against opioid manufacturer

February 6, 2018
Alabama on Tuesday filed a lawsuit against the manufacturer of OxyContin and other opioids, becoming the latest state seeking to hold drug companies accountable for an addiction epidemic.

Fearing abuse, US blocks generic OxyContin (Update)

April 16, 2013
U.S. health regulators will require generic versions of the best-selling painkiller OxyContin to include recent formulation changes designed to make the pill harder to abuse.

US city sues maker of painkiller OxyContin

January 20, 2017
A small US city on Thursday filed a lawsuit against Purdue Pharma, the maker of the pain reliever OxyContin, accusing the company of helping fuel an opioid crisis that has devastated the town.

OxyContin maker bows out of meeting on harder-to-abuse drug

June 30, 2015
The makers of the potent painkiller OxyContin have pulled out of a federal meeting to review the company's harder-to-abuse version of the much-debated drug.

Recommended for you

Study: What patients really think about opioid vs non-opioid medications for chronic pain

August 14, 2018
Prescriptions of opioids for chronic pain has increased dramatically since the 1990s in spite of their known harms. Despite a shortage of scientific studies on the long-term effectiveness of opioids such as morphine, oxycodone ...

Doctors nudged by overdose letter prescribe fewer opioids

August 9, 2018
In a novel experiment, doctors got a letter from the medical examiner's office telling them of their patient's fatal overdose. The response: They started prescribing fewer opioids.

Unwise opioids for wisdom teeth: Study shows link to long-term use in teens and young adults

August 7, 2018
Getting wisdom teeth removed may be a rite of passage for many teens and young adults, but the opioid painkiller prescriptions that many of them receive could set them on a path to long-term opioid use, a new study finds.

Benzodiazepine and related drug prescriptions have increased among young people in Sweden

August 7, 2018
The prevalence rate of prescriptions for benzodiazepines and benzodiazepine-related drugs (BZD)—medications used to treat anxiety, insomnia, epilepsy and other neuropsychiatric conditions—increased by 22% between 2006 ...

Behavioral nudges lead to striking drop in prescriptions of potent antipsychotic

August 1, 2018
A study led by Columbia University's Mailman School of Public Health has found that letters targeting high prescribers of Seroquel (quetiapine), an antipsychotic with potentially harmful side effects in the elderly, significantly ...

US opioid use not declined, despite focus on abuse and awareness of risk

August 1, 2018
Use of prescription opioids in the United States has not substantially declined over the last decade, despite increased attention to opioid abuse and awareness of their risks, finds a study published by The BMJ today.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

gzurbay
not rated yet Feb 10, 2018
Nothing like permitting a company to close the barn door after all the horses are out and the scamming of sales way in excess of the prescription need have flourished and established a presence in the medical system. Why should society not demand criminal punishment for what has been done with total lack of self oversight?? As always white collar crime takes a toll - and is not brought to justice. No wonder it seems the criminal element is in charge of "business".

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.